Syndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) will present at the Stifel 2020 Virtual Healthcare Conference on November 18, 2020, at 1:20 p.m. ET. CEO Briggs W. Morrison will discuss the company's innovative cancer therapies pipeline, which includes SNDX-5613, axatilimab, and entinostat. A live webcast of the presentation can be accessed through the Investor section of Syndax's website, where a replay will also be available.

Positive

• Syndax's pipeline includes promising cancer therapies like SNDX-5613, axatilimab, and entinostat.

Negative

• None.

WALTHAM, Mass., Nov. 11, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, will present at the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020 at 1:20 p.m. ET.

A live webcast of the presentation can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time. 

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn. 

Syndax Contacts

Investor Contact
Melissa Forst
Argot Partners
melissa@argotpartners.com 
Tel 212.600.1902

Media Contact
Ted Held
ted.held@gcihealth.com
Tel 212.798.9842

SNDX-G

 

View original content:http://www.prnewswire.com/news-releases/syndax-announces-presentation-at-stifel-2020-virtual-healthcare-conference-301170655.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

What date will Syndax present at the Stifel 2020 Virtual Healthcare Conference?

Syndax will present on November 18, 2020.

Who is presenting Syndax's pipeline at the conference?

CEO Briggs W. Morrison will present at the conference.

What time is Syndax's presentation scheduled at the conference?

The presentation is scheduled for 1:20 p.m. ET.

Where can I watch Syndax's live presentation?

The live presentation can be accessed from the Investor section of Syndax's website.

What are the key therapies in Syndax's pipeline?

The key therapies include SNDX-5613, axatilimab, and entinostat.